Literature DB >> 26599520

A systematic review to determine the most effective interventions to increase water intake.

Teresa X W Chua1,2, Neha S Prasad1,2, Gopala K Rangan2,3, Margaret Allman-Farinelli1, Anna M Rangan4.   

Abstract

BACKGROUND: Maintaining adequate fluid intake has been hypothesized to be beneficial for the progression of chronic kidney disease (CKD). The aim of this study was to undertake a systematic review to determine the most effective interventions to increase water intake.
METHODS: Six electronic databases were searched from 1910 until March 2015 in the English language. Additional sources through hand-searches, expert recommendations and reviews were checked. Intervention studies increasing water intake in adults through non-pharmacological methods were eligible for inclusion. The quality of included studies was assessed.
RESULTS: A total of 950 studies were found of which 16 met the inclusion criteria. Eight studies were randomized controlled trials, and seven studies spanned 6 months or longer. The study populations varied and included patients with recurrent nephrolithiasis (n = 6), autosomal dominant polycystic kidney disease (n = 3), CKD (n = 1), urinary tract infection (n = 1) and other miscellaneous conditions (n = 5). The quality of the studies was mostly neutral (63%) with no studies of high quality. Interventions ranged from instruction alone to self-monitoring tools, providing water bottles and counselling and education. Most interventions successfully increased water intake with 13 studies reporting an increase of at least 500 mL. The most effective strategies were instruction and self-monitoring using urine dipstick or 24 h urine volume.
CONCLUSION: All interventions carried out in the studies succeeded in increasing water intake, with none leading to decreases in intake, and these could be implemented in potential clinical trials in CKD. However, more high quality long-term intervention studies are required to further validate findings.
© 2015 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  chronic kidney disease; intake; intervention; review; systematic; water

Mesh:

Year:  2016        PMID: 26599520     DOI: 10.1111/nep.12675

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  4 in total

1.  UPDATE - Canadian Urological Association guideline: Evaluation and medical management of kidney stones.

Authors:  Naeem Bhojani; Jennifer Bjazevic; Brendan Wallace; Linda Lee; Kamaljot S Kaler; Marie Dion; Andrea Cowan; Nabil Sultan; Ben H Chew; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2022-06       Impact factor: 2.052

2.  Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).

Authors:  Annette T Y Wong; Carly Mannix; Jared J Grantham; Margaret Allman-Farinelli; Sunil V Badve; Neil Boudville; Karen Byth; Jessie Chan; Susan Coulshed; Marie E Edwards; Bradley J Erickson; Mangalee Fernando; Sheryl Foster; Imad Haloob; David C H Harris; Carmel M Hawley; Julie Hill; Kirsten Howard; Martin Howell; Simon H Jiang; David W Johnson; Timothy L Kline; Karthik Kumar; Vincent W Lee; Maureen Lonergan; Jun Mai; Philip McCloud; Anthony Peduto; Anna Rangan; Simon D Roger; Kamal Sud; Vincent Torres; Eswari Vilayur; Gopala K Rangan
Journal:  BMJ Open       Date:  2018-01-21       Impact factor: 2.692

3.  Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease.

Authors:  Wen-Ching Tran; David Huynh; Tea Chan; Catherine A Chesla; Meyeon Park
Journal:  BMC Nephrol       Date:  2017-07-05       Impact factor: 2.388

4.  Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial.

Authors:  Ragada El-Damanawi; Michael Lee; Tess Harris; Laura B Mader; Simon Bond; Holly Pavey; Richard N Sandford; Ian B Wilkinson; Alison Burrows; Przemyslaw Woznowski; Yoav Ben-Shlomo; Fiona E Karet Frankl; Thomas F Hiemstra
Journal:  BMJ Open       Date:  2018-05-09       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.